Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

402 Views

ViewAttendees 26

Session: New Antimicrobials and ID Diagnostics in the Pipeline - Bacterial

48 - Cefepime-Taniborbactam, Venatorx Pharmaceuticals, Inc.

Thursday, October 20, 2022

8:10 AM – 8:20 AM US ET

Location: 145 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Speaker(s)

Paul C. McGovern, MD

Senior Vice President, Medical Sciences
Venatorx Pharmaceuticals
Malvern, PA, United States

Disclosure: Disclosure(s): Paratek Pharmaceuticals: Stocks/Bonds (); Venatorx Pharmaceuticals: employee (), Stocks/Bonds ()

Disclosure(s):

Paul C. McGovern, MD: Paratek Pharmaceuticals: Stocks/Bonds (); Venatorx Pharmaceuticals: employee (), Stocks/Bonds ()